ADAPALENE | A201000 | ACTAVIS MID ATLANTIC LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Galderma Laboratories LP et al v. Actavis Mid Atlantic LLC 2 patentsANDA 2010006-[3-(1-adamantyl)-4methoxyphenyl]-2-naphthoic acid (adapalene) | D. Del. | 2010-10-15 | Terminated 2012-10-25 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.5056
per gm
Lowest NADAC/Unit
$0.5056
per gm
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00472012645ADAPALENE 0.3% GEL | $0.5056 | GM | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.